Drug Profile
Research programme: ear disorder therapeutics - Otonomy
Alternative Names: OTO-203; Sustained-release anti-infective for otitis media - OtonomyLatest Information Update: 01 May 2023
Price :
$50
*
At a glance
- Originator Otonomy
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Ear disorders; Tinnitus